Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction

Zhong Zhao, Hanna Ksiezak-Reding, Silvana Riggio, Vahram Haroutunian, Giulio M. Pasinetti

Research output: Contribution to journalArticlepeer-review

133 Scopus citations

Abstract

Schizophrenia is associated with abnormalities in glucose metabolism that may lead to insulin resistance and a 3 fold higher incidence of type II diabetes mellitus. The goal of the present studies was to assess the role of insulin-dependent Akt signaling in schizophrenia and in animal and cellular models of insulin resistance. Our studies revealed a functional decrease in insulin receptor (IR)-mediated signal transduction in the dorsolateral prefrontal cortex (BA46) of medicated schizophrenics relative to control patients using post-mortem brain material. We found ∼ 50% decreases in the content and autophosphorylation levels of IRβ and ∼ 76-78% decreases in Akt content and activity (pSer473-Akt). The inhibition of IRβ signaling was accompanied by an elevated content of glycogen synthase kinase (GSK)-3α and GSK-3β without significant changes in phospho-Ser21/9 GSK-3α/β levels. A cellular model of insulin resistance was induced by IRβ knockdown (siRNA). As in schizophrenia, the IRβ knockdown cells demonstrated a reduction in the Akt content and activity. Total GSK-3α/β content remained unaltered, but phospho-Ser21/9 GSK-3α/β levels were reduced indicating a net increase in the overall enzyme activity similar to that in schizophrenia. Insulin resistance phenotype was induced in mice by treatment with antipsychotic drug, clozapine. Behavioral testing showed decreases in startle response magnitude in animals treated with clozapine for 68 days. The treatment resulted in a functional inhibition of IRβ but the Akt activation status remained unaltered. Changes in GSK-3α/β were consistent with a net decrease in the enzyme activity, as opposed to that in schizophrenia. The results suggest that alterations in insulin-dependent Akt signaling in schizophrenia are similar to those observed in our cellular but not animal models of insulin resistance. In animal model, clozapine ameliorates IRβ deficits at the GSK-3α/β level, which may justify its role in treatment of schizophrenia. Our studies suggest that aberrant IR function may be important in the pathophysiology of schizophrenia.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalSchizophrenia Research
Volume84
Issue number1
DOIs
StatePublished - May 2006
Externally publishedYes

Keywords

  • Akt
  • Glycogen synthase kinase 3α
  • Glycogen synthase kinase 3β
  • Insulin receptor
  • Insulin resistance
  • Prefrontal cortex
  • Schizophrenia

Fingerprint

Dive into the research topics of 'Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction'. Together they form a unique fingerprint.

Cite this